Trial NCT04671420

View at ClinicalTrials.gov 
Org. Study IDs: HLX01-FL03

Last trial update was posted on 2020-12-17

MeSH Interventions

Rituximab

MeSH Conditions

Lymphoma Lymphoma, Follicular

Other Conditions

CD20-positive Follicular Lymphoma, With Low Tumour Burden

Stopping Reasons

sponsor strategy decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID